Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 10th November 2022, received from Registrar and Share Transfer Agent of the company (viz., MAS Services Limited), comprising information related to issuance of letter(s) of confirmation against duplicate share certificates in electronic mode, in compliance with SEBI Circular No. SEBI/HO/MIRSD/ MIRSD_RTAMB/P/CIR/2022/8 dated 25th January 2022.
11-11-2022

Morepen Lab Standalone September 2022 Net Sales at Rs 383.34 crore, up 3.78% Y-o-Y

 NULL
11-11-2022
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Statement Of Deviation Or Variation In Utilization Of Funds Raised Pursuant To Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, please note that there is no deviation or variation in utilization of funds raised, in the quarter ended 30th September 2022. Please find enclosed nil statement of deviation or variation in this regard.
10-11-2022
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Please find enclosed the Investors Presentation (Q2' FY23) November 2022, based on the financial performance of the company for the quarter and half year ended 30th September 2022.
10-11-2022
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Results-Financial Results For The Quarter And Half Year Ended September 30, 2022

 This is to inform you that the Board of Directors of the company, in their meeting held on Thursday, 10th November 2022 (commenced at 11:00 A.M. and concluded at 01:25 P.M.), have, inter-alia, considered and approved the unaudited standalone and consolidated financial results of the company for the quarter and half year ended 30th September 2022, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
10-11-2022
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Results-Financial Results For The Quarter And Half Year Ended September 30, 2022

 This is to inform you that the Board of Directors of the company, in their meeting held on Thursday, 10th November 2022 (commenced at 11:00 A.M. and concluded at 01:25 P.M.), have, inter-alia, considered and approved the unaudited standalone and consolidated financial results of the company for the quarter and half year ended 30th September 2022, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
10-11-2022
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 03rd November 2022, received from Registrar and Share Transfer Agent of the company (viz., MAS Services Limited), regarding loss of share certificate of the company. In terms of SEBI Circular No. SEBI / HO / MIRSD / MIRSD_RTAMB / P / CIR /2022/8 dated 25th January 2022, the company shall issue 'Letter of Confirmation' to the concerned shareholder after compliance of requisite formalities.
04-11-2022
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Board Meeting Intimation for Consideration And Approval Of The Standalone And Consolidated Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended 30Th September 2022

 MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 ,inter alia, to consider and approve the standalone and consolidated un-audited financial results of the company for the quarter and half year ended 30th September 2022.
03-11-2022
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 10th October 2022, received from Registrar and Share Transfer Agent of the company (viz., MAS Services Limited), comprising information related to issuance of letter of confirmation against duplicate share certificate in electronic mode, in compliance with SEBI Circular No. SEBI/HO/MIRSD/ MIRSD_RTAMB/P/CIR/2022/8 dated 25th January 2022.
11-10-2022
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 06th October 2022, received from Registrar and Share Transfer Agent of the company (viz., MAS Services Limited), regarding loss of share certificates of the company. In terms of SEBI Circular No. SEBI / HO / MIRSD / MIRSD_RTAMB / P / CIR /2022/8 dated 25th January 2022, the company shall issue 'Letter of Confirmation' to the concerned shareholder after compliance of requisite formalities.
06-10-2022
Next Page
Close

Let's Open Free Demat Account